Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 2
2000 2
2001 1
2002 1
2003 1
2004 1
2006 2
2007 3
2008 3
2009 2
2010 1
2013 1
2014 2
2015 3
2017 1
2018 1
2020 2
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
ISH-based HER2 diagnostics.
Rüschoff J, Nagelmeier I, Jasani B, Stoss O. Rüschoff J, et al. Among authors: stoss o. Pathologe. 2021 Nov;42(Suppl 1):62-68. doi: 10.1007/s00292-020-00878-6. Epub 2020 Dec 21. Pathologe. 2021. PMID: 33346874 Review. English.
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer.
Van Cutsem E, Bang YJ, Feng-Yi F, Xu JM, Lee KW, Jiao SC, Chong JL, López-Sanchez RI, Price T, Gladkov O, Stoss O, Hill J, Ng V, Lehle M, Thomas M, Kiermaier A, Rüschoff J. Van Cutsem E, et al. Among authors: stoss o. Gastric Cancer. 2015 Jul;18(3):476-84. doi: 10.1007/s10120-014-0402-y. Epub 2014 Jul 20. Gastric Cancer. 2015. PMID: 25038874 Free PMC article. Clinical Trial.
[ISH-based HER2 diagnostics].
Rüschoff J, Nagelmeier I, Jasani B, Stoss O. Rüschoff J, et al. Among authors: stoss o. Pathologe. 2020 Nov;41(6):606-613. doi: 10.1007/s00292-020-00841-5. Pathologe. 2020. PMID: 33001242 Review. German.
Emerging therapeutic targets in chronic heart failure: part II.
Roenicke V, Leclair S, Hoffmann A, Becker M, Szado T, Kirsch T, Stoss O, Navé BT, Henkel T. Roenicke V, et al. Among authors: stoss o. Expert Opin Ther Targets. 2003 Feb;7(1):49-59. doi: 10.1517/14728222.7.1.49. Expert Opin Ther Targets. 2003. PMID: 12556202 Review.
Interlaboratory concordance of PD-L1 immunohistochemistry for non-small-cell lung cancer.
Scheel AH, Baenfer G, Baretton G, Dietel M, Diezko R, Henkel T, Heukamp LC, Jasani B, Jöhrens K, Kirchner T, Lasitschka F, Petersen I, Reu S, Schildhaus HU, Schirmacher P, Schwamborn K, Sommer U, Stoss O, Tiemann M, Warth A, Weichert W, Wolf J, Büttner R, Rüschoff J. Scheel AH, et al. Among authors: stoss o. Histopathology. 2018 Feb;72(3):449-459. doi: 10.1111/his.13375. Epub 2017 Nov 21. Histopathology. 2018. PMID: 28851100
[ErbB2 diagnostics in breast cancer--an update].
Rüschoff J, Nagelmeier I, Hofmann M, Henkel T, Stoss O. Rüschoff J, et al. Among authors: stoss o. Pathologe. 2009 Mar;30(2):147-55. doi: 10.1007/s00292-009-1126-3. Pathologe. 2009. PMID: 19214513 German.
Emerging therapeutic targets in chronic heart failure: part I.
Roenicke V, Leclair S, Hoffmann A, Becker M, Szado T, Kirsch T, Stoss O, Navé BT, Henkel T. Roenicke V, et al. Among authors: stoss o. Expert Opin Ther Targets. 2002 Dec;6(6):649-58. doi: 10.1517/14728222.6.6.649. Expert Opin Ther Targets. 2002. PMID: 12472378 Review.
[Her-2/neu analysis--new data?].
Gaiser T, Hofmann M, Stoss O, Henkel T, Rüschoff J. Gaiser T, et al. Among authors: stoss o. Verh Dtsch Ges Pathol. 2006;90:107-13. Verh Dtsch Ges Pathol. 2006. PMID: 17867586 German.
24 results